Dr Richard Lerner, DVM | |
2 Central St, Framingham, MA 01701-4163 | |
(212) 444-8159 | |
Not Available |
Full Name | Dr Richard Lerner |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 2 Central St, Framingham, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508290040 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | VT 4738 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Richard Lerner, DVM 2 Central St, Framingham, MA 01701-4163 Ph: (212) 444-8159 | Dr Richard Lerner, DVM 2 Central St, Framingham, MA 01701-4163 Ph: (212) 444-8159 |
News Archive
Osteoporosis is estimated to affect 200 million women across the world. In Germany, the prevalence of this chronic disease among people aged 50 years and older is around 15%.
Researchers at UT Southwestern Medical Center at Dallas have used canine DNA to identify a genetic mutation mechanism they believe is responsible for rapid evolutionary changes in the physical appearance of many species.
Angiogenesis, the growth of new blood vessels, plays a critical role in several chronic human diseases, including metastatic cancer. In fact, several new anticancer therapies are designed to starve tumors by shutting down angiogenesis, but the lack of a good assay for quantifying angiogenesis in the body has hampered the development of effective antiangiogenesis therapies.
According to a new CBS News poll, "two in three Americans call the health care reforms being debated by lawmakers confusing; only 31 percent said they have a clear understanding of the proposed changes. Sixty-seven percent of those questioned said the reform ideas were confusing. This evaluation cuts across party lines, with majorities of both Republicans (69 percent) and Democrats (58 percent) saying the current proposals are confusing."
Baxter International Inc. today announced the commercial launch of HYLENEX recombinant (hyaluronidase human injection) for use in pediatric rehydration at the 2009 American College of Emergency Physicians (ACEP) scientific assembly (Boston). HYLENEX, an enzyme, allows fluids to be administered under the skin (subcutaneously) rather than through a vein.
› Verified 3 days ago
Neli Azimi, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Metrowest Med Dept Of Medical Education, Second Floor, Framingham, MA 01702 Phone: 508-383-1555 | |
Pramod B Thaker, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1620 Worcester Rd, No 348b, Framingham, MA 01702 Phone: 508-875-2310 |